Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Joachim Baumgart

Transplant Conditioning With Treosulfan/Fludarabine With or Without TBI. A Randomized Phase II Trial in Patients With MDS and AML

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2018

English

Related publications

Missing HLA C Group 1 Ligand in Patients With AML and MDS Is Associated With Reduced Risk of Relapse and Better Survival After Allogeneic Stem Cell Transplantation With Fludarabine and Treosulfan Reduced Toxicity Conditioning

American Journal of Hematology

Hematology

2017

English

Glasdegib in Combination With Cytarabine and Daunorubicin in Patients With AML or High-Risk MDS: Phase 2 Study Results

American Journal of Hematology

Hematology

2018

English

Fludarabine and 2-Gy TBI Is Superior to 2 Gy TBI as Conditioning for HLA-Matched Related Hematopoietic Cell Transplantation: A Phase III Randomized Trial

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2013

English

Randomized Phase II Trial Designs With Biomarkers

Journal of Clinical Oncology

English

Randomized Phase II Trial of Adjuvant Hepatic Arterial Infusion and Systemic Chemotherapy With or Without Bevacizumab in Patients With Resected Hepatic Metastases From Colorectal Cancer

Journal of Clinical Oncology

English

WT1 Vaccination in AML and MDS: A Pilot Trial With Synthetic Analog Peptides

American Journal of Hematology

Hematology

2015

English

Reduced-Intensity Conditioning Using Fludarabine With Either Antithymocyte Globulin and BU, or Low-Dose TBI Allowing Allogeneic Hematopoietic SCT

Bone Marrow Transplantation

Transplantation

Hematology

2009

English

Allogeneic Stem Cell Transplantation After Conditioning With Treosulfan, Etoposide and Cyclophosphamide for Patients With ALL: A Phase II-study on Behalf of the German Cooperative Transplant Study Group and ALL Study Group (GMALL)

Bone Marrow Transplantation

Transplantation

Hematology

2015

English

Deferasirox in MDS Patients With Transfusion-Caused Iron Overload—a Phase-Ii Study

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Joachim Baumgart

Transplant Conditioning With Treosulfan/Fludarabine With or Without TBI. A Randomized Phase II Trial in Patients With MDS and AML

Related publications

Missing HLA C Group 1 Ligand in Patients With AML and MDS Is Associated With Reduced Risk of Relapse and Better Survival After Allogeneic Stem Cell Transplantation With Fludarabine and Treosulfan Reduced Toxicity Conditioning

Glasdegib in Combination With Cytarabine and Daunorubicin in Patients With AML or High-Risk MDS: Phase 2 Study Results

Fludarabine and 2-Gy TBI Is Superior to 2 Gy TBI as Conditioning for HLA-Matched Related Hematopoietic Cell Transplantation: A Phase III Randomized Trial

Randomized Phase II Trial Designs With Biomarkers

Randomized Phase II Trial of Adjuvant Hepatic Arterial Infusion and Systemic Chemotherapy With or Without Bevacizumab in Patients With Resected Hepatic Metastases From Colorectal Cancer

WT1 Vaccination in AML and MDS: A Pilot Trial With Synthetic Analog Peptides

Reduced-Intensity Conditioning Using Fludarabine With Either Antithymocyte Globulin and BU, or Low-Dose TBI Allowing Allogeneic Hematopoietic SCT

Allogeneic Stem Cell Transplantation After Conditioning With Treosulfan, Etoposide and Cyclophosphamide for Patients With ALL: A Phase II-study on Behalf of the German Cooperative Transplant Study Group and ALL Study Group (GMALL)

Deferasirox in MDS Patients With Transfusion-Caused Iron Overload—a Phase-Ii Study